Drug & medication recalls Moderate risk

Testosterone Cypionate Injection recalled over manufacturing violations

Recall date
April 10, 2025
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Eugia US LLC recalls Testosterone Cypionate Injection, USP, CIII, 200mg per mL, Rx only, 1mL Single-Dose Vial, Distributed by Eugia US LLC,…
Recall number
D-0363-2025
FDA classification
Class II
Brand / firm
Eugia US LLC
Sold / distributed
Nationwide USA

Why it was recalled

cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Testosterone Cypionate Injection, USP, CIII, 200mg per mL, Rx only, 1mL Single-Dose Vial, Distributed by Eugia US LLC, E. Windsor, NJ, Manufactured by: Eugia Specialties Limited, Telangana State, India, NDC 55150-277-01

Get recall alerts

Free email alert whenever Eugia US LLC has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Eugia US LLC